These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 38318177)

  • 1. EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms.
    Li L; Zhang D; Cao X
    Front Immunol; 2024; 15():1320689. PubMed ID: 38318177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
    Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
    Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
    Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
    Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
    [No Abstract]   [Full Text] [Related]  

  • 4. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex.
    Bullerwell CE; Robichaud PP; Deprez PML; Joy AP; Wajnberg G; D'Souza D; Chacko S; Fournier S; Crapoulet N; Barnett DA; Lewis SM; Ouellette RJ
    Sci Rep; 2021 Jan; 11(1):1537. PubMed ID: 33452395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.
    Fedl AS; Tagoh H; Gruenbacher S; Sun Q; Schenk RL; Froussios K; Jaritz M; Busslinger M; Schwickert TA
    Nat Immunol; 2024 Sep; 25(9):1663-1677. PubMed ID: 39179932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis.
    Li J; Bhattacharya S; Zhou J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
    J Immunol; 2017 Nov; 199(10):3504-3515. PubMed ID: 28978690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
    Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
    J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early B-cell factor 1 regulates the expansion of B-cell progenitors in a dose-dependent manner.
    Åhsberg J; Ungerbäck J; Strid T; Welinder E; Stjernberg J; Larsson M; Qian H; Sigvardsson M
    J Biol Chem; 2013 Nov; 288(46):33449-61. PubMed ID: 24078629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Lymphocyte commitment program is driven by the proto-oncogene c-Myc.
    Vallespinós M; Fernández D; Rodríguez L; Alvaro-Blanco J; Baena E; Ortiz M; Dukovska D; Martínez D; Rojas A; Campanero MR; Moreno de Alborán I
    J Immunol; 2011 Jun; 186(12):6726-36. PubMed ID: 21572027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
    Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
    J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.
    Kojima Y; Kawashima F; Yasuda T; Odaira K; Inagaki Y; Yamada C; Muraki A; Noura M; Okamoto S; Tamura S; Iwamoto E; Sanada M; Matsumura I; Miyazaki Y; Kojima T; Kiyoi H; Tsuzuki S; Hayakawa F
    Int J Hematol; 2023 Jul; 118(1):65-74. PubMed ID: 37149540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
    Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
    J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor Pax5 (BSAP) transactivates the RAG-mediated V(H)-to-DJ(H) rearrangement of immunoglobulin genes.
    Zhang Z; Espinoza CR; Yu Z; Stephan R; He T; Williams GS; Burrows PD; Hagman J; Feeney AJ; Cooper MD
    Nat Immunol; 2006 Jun; 7(6):616-24. PubMed ID: 16680144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1.
    Seo W; Ikawa T; Kawamoto H; Taniuchi I
    J Exp Med; 2012 Jul; 209(7):1255-62. PubMed ID: 22665574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development.
    Timblin GA; Schlissel MS
    J Immunol; 2013 Nov; 191(9):4676-87. PubMed ID: 24068669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5.
    Roessler S; Györy I; Imhof S; Spivakov M; Williams RR; Busslinger M; Fisher AG; Grosschedl R
    Mol Cell Biol; 2007 Jan; 27(2):579-94. PubMed ID: 17101802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes.
    Lukin K; Fields S; Guerrettaz L; Straign D; Rodriguez V; Zandi S; Månsson R; Cambier JC; Sigvardsson M; Hagman J
    Eur J Immunol; 2011 Jun; 41(6):1787-93. PubMed ID: 21469119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development.
    Venigalla RK; McGuire VA; Clarke R; Patterson-Kane JC; Najafov A; Toth R; McCarthy PC; Simeons F; Stojanovski L; Arthur JS
    EMBO J; 2013 Apr; 32(7):1008-22. PubMed ID: 23463102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.